This inventor holds 2 USPTO granted patents. Top assignee: Abbott Toxicology Limited. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Barry Lillis: Innovator in Fluid Specimen Testing
Introduction
Barry Lillis is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of fluid specimen testing, holding a total of 2 patents. His work focuses on developing technologies that enhance the accuracy and efficiency of testing various body fluids.
Latest Patents
Lillis's latest patents revolve around fluid specimen testing. These patents provide technology related to testing fluid specimens, particularly apparatuses, devices, methods, systems, and kits designed to analyze fluids such as urine, saliva, and other body fluids. The goal of his inventions is to detect specified chemical components within these specimens, thereby improving diagnostic capabilities.
Career Highlights
Barry Lillis is currently associated with Abbott Toxicology Limited, where he applies his expertise in developing innovative testing solutions. His work has been instrumental in advancing the field of toxicology and fluid analysis.
Collaborations
Throughout his career, Lillis has collaborated with notable professionals, including Nigel John Fairbank, Jr. and Paul Ngui. These collaborations have contributed to the development of cutting-edge technologies in fluid specimen testing.
Conclusion
Barry Lillis stands out as an influential inventor in the realm of fluid specimen testing. His patents and ongoing work continue to shape the future of diagnostic testing, making significant strides in healthcare innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile